Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register
暂无分享,去创建一个
F. Pomero | W. Ageno | F. Dentali | A. Fontanella | S. Testa | D. Poli | B. Cosmi | A. Falanga | E. Antonucci | C. Legnani | G. Palareti | D. Imberti | N. Mumoli | D. Mastroiacovo | E. Bucherini
[1] W. Ageno,et al. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register , 2020, BMJ Open.
[2] S. Kahn,et al. Long-term treatment of venous thromboembolism. , 2020, Blood.
[3] Stefano Barco. What's the Matter with Distal Deep Vein Thrombosis? , 2019, Thrombosis and Haemostasis.
[4] Alfredo E Farjat,et al. Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry , 2019, Thrombosis and Haemostasis.
[5] W. Ageno,et al. Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA , 2019, TH Open.
[6] A. Turpie,et al. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism , 2017, Thrombosis and Haemostasis.
[7] F. Pomero,et al. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study , 2017, Vascular medicine.
[8] G. Utter,et al. Therapeutic Anticoagulation for Isolated Calf Deep Vein Thrombosis. , 2016, JAMA surgery.
[9] E. Schwarz,et al. Are New Oral Anticoagulants Safer Than Vitamin K Antagonists in the Treatment of Venous Thromboembolism? , 2016, Annals of emergency medicine.
[10] G. Lip,et al. Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism , 2016, Heart.
[11] Elie A Akl,et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. , 2012, Chest.
[12] S. Schulman,et al. Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH , 2015, Journal of thrombosis and haemostasis : JTH.
[13] N. Magrini,et al. The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation , 2015, PloS one.
[14] M. S. Mcmurtry,et al. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention. , 2015, Thrombosis research.
[15] G. Palareti. How I treat isolated distal deep vein thrombosis (IDDVT). , 2014, Blood.
[16] G. Palareti,et al. Isolated distal deep vein thrombosis: what we know and what we are doing , 2012, Journal of thrombosis and haemostasis : JTH.
[17] G. Lessiani,et al. Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: The blind, prospective CALTHRO study , 2010, Thrombosis and Haemostasis.
[18] Georg Heinze,et al. Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model , 2010, Circulation.
[19] D Bergqvist,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.
[20] M. Monreal,et al. Comparison of the clinical history of symptomatic isolated distal deep‐vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients , 2009, Journal of thrombosis and haemostasis : JTH.
[21] H. Büller,et al. Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study , 2009, Journal of thrombosis and haemostasis : JTH.
[22] W. Ageno,et al. Do Italian vascular centers look for isolated calf deep vein thrombosis? Analysis of isolated calf deep vein thromboses included in the ''Master'' Registry. , 2008, International Angiology.
[23] H. Büller,et al. Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. , 2008, JAMA.
[24] H. Bounameaux,et al. Clinical relevance of distal deep vein thrombosis , 2005, Thrombosis and Haemostasis.
[25] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[26] Matthias Egger,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.
[27] H. Bounameaux,et al. Clinical relevance of distal deep vein thrombosis , 2005, Thrombosis and Haemostasis.
[28] S. Schulman,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.
[29] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] I. Durieu,et al. Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis , 2001, Circulation.
[32] Vittorio Pengo,et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.
[33] Olle Linder,et al. A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism , 1995 .
[34] S. Schulman,et al. A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism , 1996 .
[35] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .